Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nuclear Medicine and Biology

• Publication date

  2015-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.nucmedbio.2015.06.001PMID 26162582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma.

  2015cited by this paper
• Factors affecting ¹⁸F FDOPA standardized uptake value in patients with primary brain tumors after treatment.

  2015cited by this paper
• Intra-individual comparison of 18 F-FET and 18 F-DOPA in PET imaging of recurrent brain tumors

  2014influential reference
• Distance informed Track-Weighted Imaging (diTWI): A framework for sensitising streamline information to neuropathology

  2014cited by this paper
• 18F-FDOPA PET for Differentiating Recurrent or Progressive Brain Metastatic Tumors from Late or Delayed Radiation Injury After Radiation Treatment

  2014cited by this paper
• Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery

  2014cited by this paper
• 6-[18F]Fluoro-L-DOPA: A Well-Established Neurotracer with Expanding Application Spectrum and Strongly Improved Radiosyntheses

  2014cited by this paper
• Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.

  2014influential reference
• Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.

  2014cited by this paper
• Prospective Comparison of 99mTc-GH SPECT/CT and 18F-FDOPA PET/CT for Detection of Recurrent Glioma: A Pilot Study

  2013influential reference
• Correlation of MRI-Derived Apparent Diffusion Coefficients in Newly Diagnosed Gliomas with [18F]-Fluoro-L-Dopa PET: What Are We Really Measuring with Minimum ADC?

  2013cited by this paper
• Early prediction of treatment response in advanced gliomas with (18)F-dopa positron-emission tomography.

  2013cited by this paper
• MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high‐grade gliomas

  2013cited by this paper
• Comparative diagnostic accuracy of contrast-enhanced MRI and 18F-FDOPA PET-CT in recurrent glioma

  2013cited by this paper
• High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.

  2013cited by this paper
• Voxel-based analysis of 201Tl SPECT for grading and diagnostic accuracy of gliomas: comparison with ROI analysis

  2013cited by this paper
• Evaluation of Quantitative Criteria for Glioma Grading With Static and Dynamic 18F-FDopa PET/CT

  2013cited by this paper
• Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.

  2013influential reference
• 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT

  2013influential reference
• The role of LAT1 in 18F-DOPA uptake in malignant gliomas

  2012cited by this paper
• Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival

  2012cited by this paper
• PET with radiolabeled aminoacid.

  2012cited by this paper
• Angiogenesis and hypoxia in glioblastoma: a focus on cancer stem cells.

  2012cited by this paper
• Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports.

  2012cited by this paper
• Perioperative single photon emission computed tomography in predicting survival of malignant glioma patients.

  2012cited by this paper
• Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas

  2012cited by this paper
• 18F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas

  2012cited by this paper
• Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective

  2012cited by this paper
• 18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab.

  2012cited by this paper
• Comparative study of 18F-DOPA, 13N-Ammonia and F18-FDG PET/CT in primary brain tumors

  2011cited by this paper
• Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis

  2011cited by this paper
• Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.

  2011cited by this paper
• F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study

  2011cited by this paper
• Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy.

  2011cited by this paper
• Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.

  2011cited by this paper
• Comparative evaluation of 18F-FDOPA, 13N-AMMONIA, 18F-FDG PET/CT and MRI in primary brain tumors - A pilot study

  2011influential reference
• GMP production of [18F]FDOPA and issues concerning its quality analyses as in USP “Fluorodopa F 18 Injection”

  2011cited by this paper
• Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

  2010cited by this paper
• Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

  2010cited by this paper
• Correlation of 6-18F-Fluoro-l-Dopa PET Uptake with Proliferation and Tumor Grade in Newly Diagnosed and Recurrent Gliomas

  2010influential reference
• Management of Low-Grade Glioma

  2010cited by this paper
• 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.

  2009influential reference
• Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method.

  2009cited by this paper
• Three-Step, “One-Pot” Radiosynthesis of 6-Fluoro-3,4-Dihydroxy-l-Phenylalanine by Isotopic Exchange

  2009cited by this paper
• A Comparative Study of

  2009cited by this paper
• Comparative Evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for Metabolic Imaging of Low Grade Gliomas

  2009influential reference
• Pseudoprogression and pseudoresponse in the treatment of gliomas

  2009cited by this paper
• Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

  2009cited by this paper
• POSITRON EMISSION TOMOGRAPHY‐GUIDED VOLUMETRIC RESECTION OF SUPRATENTORIAL HIGH‐GRADE GLIOMAS: A SURVIVAL ANALYSIS IN 66 CONSECUTIVE PATIENTS

  2009cited by this paper
• Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms

  2009cited by this paper
• Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging

  2009cited by this paper
• Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic.

  2009cited by this paper
• Electrophilic synthesis of 6-[18F]fluoro-L-DOPA using post-target produced [18F]F2

  2008cited by this paper
• Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival

  2008cited by this paper
• Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT.

  2008cited by this paper
• MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.

  2008cited by this paper
• Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

  2008cited by this paper
• Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.

  2007cited by this paper
• 18F-FDOPA Kinetics in Brain Tumors

  2007cited by this paper
• Trifluoromethanesulfonic acid, an alternative solvent medium for the direct electrophilic fluorination of DOPA: new syntheses of 6-[18F]fluoro-L-DOPA and 6-[18F]fluoro-D-DOPA

  2007cited by this paper
• Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.

  2006cited by this paper
• Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas.

  2006cited by this paper
• Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas

  2006cited by this paper
• [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.

  2006cited by this paper
• 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.

  2006influential reference
• Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas

  2005cited by this paper
• Brain tumors

  2005cited by this paper
• Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

  2005cited by this paper
• 201Tl-SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis

  2004cited by this paper
• Highly Enantioselective Synthesis of No‐Carrier‐Added 6‐[18F]Fluoro‐L‐dopa by Chiral Phase‐Transfer Alkylation

  2004cited by this paper
• PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.

  2004cited by this paper
• 3-O-methyl-6-18F-fluoro-L-dopa, a new tumor imaging agent: investigation of transport mechanism in vitro.

  2004cited by this paper
• Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

  2004cited by this paper
• The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model

  2004cited by this paper
• Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine

  2003cited by this paper
• Positron emission tomography imaging of brain tumors.

  2003cited by this paper
• Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy.

  2003cited by this paper
• Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.

  2003cited by this paper
• Prediction of Pathology and Survival by FDG PET in Gliomas

  2003cited by this paper
• Primary brain tumours in adults.

  2003cited by this paper
• Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach

  2003influential reference
• Factors influencing survival in high-grade gliomas.

  2003cited by this paper
• Brain tumours : an encyclopedic approach

  2003cited by this paper
• Primary brain tumours in adults.

  2003cited by this paper
• Positron emission tomography imaging of brain tumors.

  2002cited by this paper
• Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy.

  2002cited by this paper
• Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.

  2002cited by this paper
• Comparison of thallium-201 uptake and retention indices for evaluation of brain lesions with SPECT.

  2002cited by this paper
• Brain tumors.

  2001cited by this paper
• Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

  2001cited by this paper
• Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

  2000cited by this paper
• Clinical application of 201Tl SPECT imaging of brain tumors.

  2000cited by this paper
• Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.

  2000cited by this paper
• Fully automated synthesis module for the high yield one-pot preparation of 6-[]fluoro-l-DOPA

  1999cited by this paper
• 6‐[18F]Fluoro‐L‐DOPA by radiofluorodestannylation: a short and simple synthesis of a new labelling precursor

  1998cited by this paper
• Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?

  1998cited by this paper
• The role of thallium-201 uptake and retention in intracranial tumors after radiotherapy.

  1997cited by this paper
• Modeling of fluorine-18-6-fluoro-L-Dopa in humans.

  1996cited by this paper

• The molecular footprint of the serotoninergic system in human glioblastoma cells

  2025cites this paper
• PET/CT in the Imaging of CNS Tumors.

  2025cites this paper
• Automation of Copper-Mediated 18F-Fluorination of Aryl Pinacol Boronates Using 4-Dimethylaminopyridinium Triflate

  2024cites this paper
• Nuclear Medicine Imaging Techniques in Glioblastomas

  2024cites this paper
• ASL, DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating glioma recurrence from post-treatment changes

  2024cites this paper
• Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme

  2023cites this paper
• Nuclear medicine and radiotherapy in the clinical management of glioblastoma patients

  2022cites this paper
• A Systematic Review of Amino Acid PET Imaging in Adult-Type High-Grade Glioma Surgery: A Neurosurgeon’s Perspective

  2022cites this paper
• Positron emission tomography imaging in primary brain tumors

  2021cites this paper
• Preliminary evaluation of cerebral 18F-DOPA PET/CT in the differential diagnosis of brain lesions in inconclusive MR.

  2021cites this paper
• G-protein-coupled receptors as therapeutic targets for glioblastoma.

  2021cites this paper
• Additional Value of 18F-FDOPA Amino Acid Analog Radiotracer to Irradiation Planning Process of Patients With Glioblastoma Multiforme

  2021cites this paper
• A Phase II Study of Dose-Intensified Chemoradiation Using Biologically-Based Target Volume Definition in Patients with Newly Diagnosed Glioblastoma.

  2021cites this paper
• Long non-coding RNA PSMA3-AS1 enhances cell proliferation, migration and invasion by regulating miR-302a-3p/RAB22A in glioma

  2020cites this paper
• Recent advances of PET imaging in clinical radiation oncology

  2020cites this paper
• Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas

  2020cites this paper
• Valoración preliminar de la 18F-DOPA PET/TC cerebral en el diagnóstico diferencial de lesiones cerebrales con RM no concluyente

  2020cites this paper
• Nucleophilic Synthesis of 6-l-[18F]FDOPA. Is Copper-Mediated Radiofluorination the Answer?

  2020cites this paper
• Non-FDG PET/CT.

  2020cites this paper
• Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses

  2019cites this paper
• Comparison between 18f-Dopa and 18f-Fet Pet/Ct in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and our Experience.

  2019cites this paper
• Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma

  2019cites this paper
• Application of 82Sr/82Rb generator in neurooncology

  2019cites this paper
• PET in Neuro-Oncology

  2019cites this paper
• Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine positron emission tomography.

  2019cites this paper
• Molecular Imaging and Targeted Therapy in Neurology

  2019cites this paper
• IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT

  2019cites this paper
• Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma

  2019cites this paper
• PET in brain tumors

  2018cites this paper
• 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study

  2018cites this paper
• The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.

  2018cites this paper
• Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas

  2018cites this paper
• Effects of L-DOPA Pretreatment on the Kinetics, Migration and Carbon Ion Radiation Response of T98G Cells

  2018cites this paper
• Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors

  2018cites this paper
• PET imaging in glioma: techniques and current evidence

  2018cites this paper
• Dosimetric impact of amino acid positron emission tomography imaging for target delineation in radiation treatment planning for high-grade gliomas

  2018cites this paper
• PET/MRI: Multiparametric imaging of brain tumors.

  2017cites this paper
• Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[18F]fluoro-l-DOPA.

  2017cites this paper
• Design and utilisation of protocols to characterise dynamic PET uptake of two tracers using basis pursuit

  2017cites this paper
• [18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression

  2017cites this paper
• Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial

  2017cites this paper
• Whole-body direct 4 D parametric PET imaging employing nested generalized Patlak expectation – maximization reconstruction

  2017cites this paper
• Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors

  2016cites this paper
• On image segmentation methods applied to glioblastoma: state of art and new trends

  2016cites this paper
• Lessons in molecular imaging: the assessment of brain tumors using PET/MRI

  2016cites this paper
• Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.

  2016cites this paper
• Copper-Mediated Radiofluorination of Arylstannanes with [18F]KF

  2016cites this paper